Shukra Pharmaceuticals manufactures and markets pharmaceutical products and does laboratory testing.
The company reported a 110.2% surge in standalone net profit to Rs 1.03 crore, while revenue from operations rose 69.5% to Rs 5.39 crore in Q1 FY26 over Q1 FY25.
The scrip rose 1.98% to settle at Rs 25.71 on the BSE.
Powered by Capital Market - Live News